| 1 |
Delving the Role of Caralluma fimbriata: An Edible Wild Plant to Mitigate the Biomarkers of Metabolic Syndrome |
|
|
| Rimsha Anwar, Roshina Rabail, Allah Rakha, Marcin Bryla, Marek Roszko, Rana Muhammad Aadil, Marek Kieliszek, Yujie Chen |
|
| Oxidative Medicine and Cellular Longevity. 2022; 2022: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials |
|
|
| Ranil Jayawardena, Tormalli V. Francis, Sachith Abhayaratna, Priyanga Ranasinghe |
|
| BMC Complementary Medicine and Therapies. 2021; 21(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults |
|
|
| Amanda Rao,David Briskey,Carla dos Reis,Alistair R. Mallard |
|
| Scientific Reports. 2021; 11(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
A randomised placebo controlled clinical trial on the efficacy of Caralluma fimbriata supplement for reducing anxiety and stress in healthy adults over eight weeks |
|
|
| G. Kell,A. Rao,M. Katsikitis |
|
| Journal of Affective Disorders. 2019; 246: 619 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Preclinical Testing in Translational Animal Models of Prader-Willi Syndrome: Overview and Gap Analysis |
|
|
| K. Vanessa Carias,Rachel Wevrick |
|
| Molecular Therapy - Methods & Clinical Development. 2019; 13: 344 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Single-Case Study of Appetite Control in Prader-Willi Syndrome, Over 12-Years by the Indian Extract Caralluma fimbriata |
|
|
| Joanne Griggs |
|
| Genes. 2019; 10(6): 447 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Caralluma fimbriata
extract activity involves the 5-HT2c receptor in PWS Snord116
deletion mouse model |
|
|
| Joanne L. Griggs,Michael L. Mathai,Puspha Sinnayah |
|
| Brain and Behavior. 2018; : e01102 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
